Topics Related to Bulletins
Billing Reimbursement for second booster
Billing Guideline for use of Evusheld
Capacity building FAQs, guidance on the use of extenders, standard terms and conditions, and Provider Manual updates.
With the end of the federal Public Health Emergency (PHE) expected in the Summer of 2022, NC Medicaid providers will begin receiving reverification notices. These notices will be sent to providers with approaching reverification due dates, as well as those whose reverification was suspended during the federal PHE. The Centers for Medicare and Medicaid Services (CMS) requires that all Medicaid providers are revalidated (also referred to as reverification/recredentialing).
The Medicaid NCCI edits for the most recent quarter are published on the CMS website.
NC Medicaid received approval to increase NC Innovations Waiver capacity by 1,000 slots.
Approved for beneficiaries over the age of 21, effective July 1, 2021
EVV for Home Health in January 2023
Effective with date of service March 15, 2022, the Medicaid and NC Health Choice programs cover naloxone hydrochloride injection for intramuscular or subcutaneous use.
Effective with date of service March 2, 2022, the Medicaid and NC Health Choice programs cover plasminogen, human-tvmh lyophilized powder for reconstitution.